Replies to post #675884 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

This of course begs the question: where are all the derivative lawsuits against these market makers if the spoofing case is so strong? In any event, amending and re-filing the complaint puts everyone back to square one.

From the perspective of NWBO shareholders and valuation of our investment, this is a non-factor. Maybe from a market integrity perspective, this case could be important. But still years from getting to that point, if ever.

this spoofing case (and other manipulation cases) will remain an important and significant case in its own right, and definitely worth pursuing to the end.